Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Exploring Dabigatran and Its Impurities: Reliable Solutions from Aquigen BioIn the world of pharmaceutical development and analytical testing, the quality and reliability of reference standards are non-negotiable. This is particularly true when working with Dabigatran, a direct thrombin inhibitor widely used in anticoagulant
By: aquigenbio Whether you're part of a quality control laboratory, a research and development team, or managing regulatory filings, having access to well-characterized, traceable impurity standards is essential. That's where Aquigen Bio comes in — providing pharmaceutical and analytical professionals with high-purity materials that support compliance and innovation. Aquigen Bio: Setting the Standard in Dabigatran Impurities Aquigen Bio is a globally recognized manufacturer and supplier of pharmaceutical reference materials, offering an extensive catalog of impurities and intermediates, especially for critical APIs like Dabigatran. With a deep commitment to scientific rigor and regulatory alignment, Aquigen Bio empowers clients across the pharmaceutical value chain. https://aquigenbio.com/ Aquigen's Dabigatran Portfolio Includes: Dabigatran Impurity 13 Dabigatran Impurity 12 Dabigatran Etexilate Mesylate Dabigatran Etexilate N-oxide Dabigatran Etexilate USP Related Compound C Dabigatran Hydrobromide Dabigatran Hydrochloride Dabigatran Impurity 1 Dabigatran Impurity 10 Dabigatran Impurity 11 https://aquigenbio.com/ These reference materials are developed under strict quality control and come with comprehensive documentation including Certificates of Analysis (COA), NMR, HPLC, and Mass Spectra, ensuring traceability and reproducibility in every batch. Applications and Regulatory Significance Dabigatran impurities and intermediates are not just chemical markers — they are crucial tools for: https://aquigenbio.com/ Method validation and development Stability and forced degradation studies Impurity profiling as per ICH Q3A/B guidelines Bioanalytical method calibration https://aquigenbio.com/ Batch release and QC testing Regulatory bodies such as USFDA, EMA, MHRA, and CDSCO require pharmaceutical manufacturers to identify, quantify, and control impurities to ensure patient safety. Having access to validated and traceable impurity standards like those from Aquigen Bio is key to passing audits and maintaining global compliance. Contact aditi.aspms@ End
|
|